You are here: Home » News-CM » Companies » News
Business Standard

Alembic Pharmaceuticals announces completion of USFDA inspection at Aleor Dermaceuticals

Capital Market 

announced that (Aleor), a 60:40 Joint Venture between and Orbicular Pharmaceutical Technologies, has completed United States (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with two observations.

The inspection was carried out from 4 February 2019 to 8 February 2019.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, February 11 2019. 17:07 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU